Company Filing History:
Years Active: 2003-2004
Title: Zoltán Greff: Innovator in Pharmaceutical Chemistry
Introduction
Zoltán Greff is a prominent inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, holding 2 patents that showcase his innovative approaches to drug development.
Latest Patents
One of his latest patents is titled "Process for the preparation of a 3(2H)-pyridazinone-4-substituted amino 5-chloro derivative." This invention relates to novel processes for preparing 5-chloro-4-{3-[N-{2-(3,4-dimethoxyphenyl)-ethyl}-N-methylamino]}-propylamino-3(2H)pyridazinone and its pharmaceutically acceptable acid addition salts. An important feature of this invention is the use of 3,4,5-trichloropyridazone as the starting substance for the synthesis.
Another significant patent is focused on "8-substituted-9H-1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives, as AMPA/kainate receptor inhibitors." This disclosure relates to a novel 8-substituted-9H-1,3-dioxolo-[4,5-h][2,3]benzodiazepine compound and its pharmaceutically acceptable quaternary ammonium salts. The patent also includes a process for preparing the compound, a pharmaceutical composition containing it, and a method of treatment using the composition. The compounds possess unique competitive AMPA/kainate antagonist properties, making them useful in treating diseases where inhibition of the AMPA/kainate receptors may have a favorable effect.
Career Highlights
Zoltán Greff is associated with Egis Gyógyszergyár Rt., a leading pharmaceutical company in Hungary. His work at Egis has allowed him to focus on innovative drug development and contribute to advancements in the pharmaceutical industry.
Collaborations
He has collaborated with notable coworkers such as Gyula Simig and József Barkóczy, further enhancing the impact of his research and inventions.
Conclusion
Zoltán Greff's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the field. His work continues to influence the development of new